Digital Neurotherapy + Capacity Coaching for Polycystic Kidney Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to evaluate the feasibility and effectiveness of Digital Neurotherapy (DNT) or Capacity Coaching (CC) for managing symptoms of depression and self reported pain in Autosomal Dominant Polycystic Kidney Disease (ADPKD) compared to education alone.
Who Is on the Research Team?
Neera Dahl, MD, PhD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for people diagnosed with autosomal dominant polycystic kidney disease (ADPKD) who are experiencing symptoms of depression or pain. Specific inclusion and exclusion criteria are not listed, but participants must have ADPKD.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Capacity Coaching
- Digital Neurotherapy
- Mayo Clinic-Approved Education
Trial Overview
The study compares two new approaches—Digital Neurotherapy and Capacity Coaching—to standard educational support to see which best helps manage depression and pain in people with ADPKD.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Active Control
The Digital Neuropathy group will utilize the web-based system (REJUVENATE) for a duration of 20 minutes, 4 times per week (12 weeks)
The Capacity Coaching group will participate in calls with a board certified health and wellness coach for a duration of 60 minutes, every 2 weeks, for 6 sessions (12 weeks)
The control group will receive standard of care, Mayo Clinic approved education for a duration of 60 minutes, every 2 weeks for 6 sessions (12 weeks)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.